Palvella Therapeutics Inc (PVLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 19 | 698 | 1,373 | 0 |
| Gross Profit | 19 | 698 | 1,373 | N/A |
| Operating Expenses | 1,860 | 3,468 | 2,044 | 0 |
| Operating Income | -1,841 | -2,770 | -671 | N/A |
| Interest Expense | 181 | 114 | 109 | 0 |
| Other Income | 0 | 2 | 1 | 0 |
| Pre-tax Income | -2,022 | -2,882 | -780 | 0 |
| Net Income Continuous | -2,022 | -2,882 | -780 | N/A |
| Net Income | $-2,022 | $-2,882 | $-780 | $N/A |
| EPS Basic Total Ops | -13.60 | -19.20 | -5.60 | N/A |
| EPS Basic Continuous Ops | -13.68 | -19.49 | -5.27 | N/A |
| EPS Diluted Total Ops | -13.60 | -19.20 | -5.60 | N/A |
| EPS Diluted Continuous Ops | -13.68 | -19.49 | -5.27 | N/A |
| EBITDA(a) | $-1,752 | $-2,676 | $-576 | $N/A |